Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 11;9(5):00345-2023.
doi: 10.1183/23120541.00345-2023. eCollection 2023 Sep.

Quantitative 99mTc-albumin colloid nasal mucociliary clearance as an outcome in primary ciliary dyskinesia

Affiliations

Quantitative 99mTc-albumin colloid nasal mucociliary clearance as an outcome in primary ciliary dyskinesia

June K Marthin et al. ERJ Open Res. .

Abstract

Background: Primary ciliary dyskinesia (PCD) is an inherited disorder in which dyskinetic cilia cause impaired mucociliary clearance of upper and lower airways. Airway ciliary movement can be indirectly tested in vivo after administration of a radiolabelled tracer to the lower airways for assessment of pulmonary mucociliary clearance or to the nose for assessing nasal mucociliary clearance (NMC). With this study, we investigated NMC as a quantifiable study outcome parameter in patients with PCD.

Material and methods: This single centre proof-of-concept study on NMC velocity investigated patients with PCD across different genotypes and nasal nitric oxide (nasal NO) levels. Healthy controls were used for comparison. NMC was determined as velocity in mm·min-1 of a nasally applied 99mTc-albumin colloid tracer. Using a gamma camera, repeated dynamic series of images each lasting 30 s were acquired during a 10-minute period and digitally stored.

Results: NMC velocity was investigated in seven patients with PCD (aged 9-31 years) and five adult healthy controls. Mean NMC velocity in healthy controls (8.5 mm·min-1) was significantly higher compared with people with PCD (0.00 mm·min-1, p<0.0001). NMC was completely absent in all included patients with PCD across different PCD genotypes and regardless of nasal NO values. The success rate of the test was 100% in both groups.

Conclusion: NMC velocity discriminated highly significantly between patients with PCD and healthy controls. We suggest here a fast and feasible set up for NMC measurements that is easily applicable for any clinical trial involving PCD medication aimed for the nasal compartment, a step before or parallel to conducting clinical trials investigating whole-lung ciliary function in PCD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors J.K. Marthin, K.G. Nielsen and J. Mortensen have no conflicts of interests to disclose.

Figures

FIGURE 1
FIGURE 1
Photograph of a 10-year-old subject showing the gamma camera facing the profile of the subject during the 20 min dynamic acquisitions after administration of the radiolabelled tracer to the nasal concha media. A 57Co marker is attached to the tip of the nose and to the anterior tragus of the (left) ear leaning against the camera. The tragus marker is not visible on the photo.The photo is shown with consent from both parents and the child.

Similar articles

Cited by

References

    1. Horani A, Ferkol TW. Understanding primary ciliary dyskinesia and other ciliopathies. J Pediatr 2021; 230: 15–22. doi:10.1016/j.jpeds.2020.11.040 - DOI - PMC - PubMed
    1. Lucas JS, Davis SD, Omran H, et al. . Primary ciliary dyskinesia in the genomics age. Lancet Respir Med 2020; 8: 202–216. doi:10.1016/S2213-2600(19)30374-1 - DOI - PubMed
    1. Wallmeier J, Nielsen KG, Kuehni CE, et al. . Motile ciliopathies. Nat Rev Dis Primers 2020; 6: 77. doi:10.1038/s41572-020-0209-6 - DOI - PubMed
    1. Kobbernagel HE, Buchvald FF, Haarman EG, et al. . Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (bestcilia): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Respir Med 2020; 8: 493–505. doi:10.1016/S2213-2600(20)30058-8 - DOI - PubMed
    1. Paff T, Daniels JM, Weersink EJ, et al. . A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia. Eur Respir J 2017; 49: 1601770. doi:10.1183/13993003.01770-2016 - DOI - PubMed

LinkOut - more resources